• Contemporary ClinicContemporary Clinic
  • OTC GuideOTC Guide
  • Pharmacy Times
  • PTCEPTCE
  • Pharmacist Moms GroupPharmacist Moms Group
News
All News
FDA Updates
Press Releases
Media
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conferences
Conference Coverage
Conference Listing
Publications
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
Clinical
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Events
Upcoming Events
Upcoming Webinars
CE
Resources
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
logo
Spotlight
Community/RetailHospitalOncologyPharmacy TechnicianStudent
Clinical Role
Community/RetailHospitalOncologyPharmacy TechnicianSpecialty PharmacyStudent
Clinical
CoronavirusBrain HealthCardiovascular HealthDermatologyDiabetesFluHeart FailureHepatitis/MASHImmunizationMigrainePneumococcalVitamins and Supplements
Supplement Spotlight
October 2023 Pharmacy Technician Edition
All News
FDA Updates
Press Releases
All Videos
Digital Detail
Independent Corner
Insights
Interviews
MEDcast
Medical World News
Microsites
Peer Exchange
Perfect Consult
Podcasts
Practice Pearls
Sponsored Webcast
Student Voices
Webinars/Webcasts
Conference Coverage
Conference Listing
Pharmacy Times
Pharmacy Practice in Focus: Oncology
Pharmacy Practice in Focus: Health Systems
Pharmacy Careers
All Publications
About the Publications
Author Submission
Submit to Pharmacy Practice in Focus: Oncology
Submit to Pharmacy Practice in Focus: Health Systems
Become a Peer Reviewer
Supplements & Featured Publications
503B Compounding Pharmacy
ADHD
Allergy
Alzheimer Disease
Anxiety
Asthma
Atopic Dermatitis
Biosimilars
Bipolar Disorder
Brain Health
Breast Cancer
C. Difficile
COPD
COVID-19
Cardiovascular Health
Cervical Cancer
Cholangiocarcinoma
Cholesterol
Chronic Kidney Disease
Chronic Lymphocytic Leukemia
Classical Hematology
Colorectal Cancer
Continuous Glucose Monitoring
Cough and Cold
Depression
Dermatology
Diabetes
Digestive Health
Dry Eye Disease
Epilepsy
Eye Care
Flu
Future of Pharmacy
Gastrointestinal Cancer
Gastrointestinal Health
Gout
HER2 Breast Cancer
HIV
Heart Failure
Hematology
Hepatitis/MASH
Immunization
Immuno-oncology
Immunoglobulins
Infectious Disease
Lung Cancer
Lymphoma
Macular Degeneration
Mental Health
Migraine
Multiple Myeloma
Multiple Sclerosis
Myelofibrosis
Neurology
Neutropenia
Osteoporosis
Ovarian Cancer
Pain Management
Parkinson Disease
Pediatrics
Pharmacy Heroes
Pharmacy Management
Pneumococcal
PrEP
Prostate Cancer
Psoriasis
Psoriatic Arthritis
Psychedelics
Reimbursement
Reproductive Health
Respiratory Syncytial Virus
Rheumatoid Arthritis
Schizophrenia
Shingles
Skin Cancer
Sleep
Travel Vaccines
Veterinary Pharmacy
Vitamins and Supplements
Weight Management
Women's Health
Upcoming Events
Upcoming Webinars
CE
Clinical Forum
Cou-Co
Educated Patient
Information for the Pharmacist
Interactive Tools
Partners
Sponsored
Whiteboards
Subscribe
Advertisement

CLINICAL ROLE -

Community/Retail
| Hospital
| Oncology
| Pharmacy Technician
| Student

News

Article

May 25, 2024

Study Finds Associations Between Extreme Heat and Asthma-Related Hospital Visits in Children

Author(s):

Gillian McGovern, Associate Editor
Conference|ATS International Conference - American Thoracic Society International Conference

The findings demonstrated that daytime heat waves were associated with approximately 19% higher odds of asthma-related hospitalizations in children.

According to research presented at the 2024 American Thoracic Society International Conference, extreme heat events were associated with an increase in asthma-related hospital visits. The study demonstrates that the milder extreme heat temperatures in California, even if they do not meet the extremes of other regions, can significantly impact health in children.1

Child with asthma in hospital -- Image credit: Monkey Business | stock.adobe.com

Image credit: Monkey Business | stock.adobe.com

Extreme heat, according to the authors, has previously been associated with adverse health outcomes, particularly in pediatric patients. The study assesses the association between extreme heat and asthma exacerbation—as assessed by hospitalizations—among a pediatric population with asthma who were seeking care at the University of California San Francisco (UCSF) Benioff Children’s Hospital Oakland. The study authors noted that California—particularly the San Francisco Bay Area—were unique and considered an area of interest because the state is a coastal region that has a smaller prevalence of cooling units and air conditioners, according to the authors.1,2

For this study, the investigators used electronic health record data from Benioff Children’s Hospital. This data included hospital visits due to asthma-related events, patient demographics, and the patients’ zip codes. Additionally, the daily maximum (or daytime heat wave) and minimum (nighttime heat waves) temperatures for each population-weighted centroid of each zip code were gathered. Temperatures gathered were from June to September for each year included in the analysis.2

Further, 18 different heat wave definitions—including where the temperature exceeded the 99th, 97.5th, and 95th percentiles of the total temperature distribution of the study period for 1, 2, or 3 days—were used to evaluate the potential range in effects of different heat wave measurements. The authors designed the study to allow them to determine the association between each heat wave definition and a hospital visit, then they repeated the analysis for the Central California and Bay Area zip codes.1,2

The findings demonstrated that daytime heat waves were significantly associated with a higher risk of going to the hospital (OR: 1.21; 95% CI: 1.01, 1.45) and (OR: 1.79; 95% CI: 1.07, 2.99) for day 1 in the 95th percentile, and day 3 in the 99th percentile, respectively. Further, there was a positive association between heat and asthma-related hospital visits in the Bay Area (OR: 1.83; 95% CI: 1.08, 3.11); however, no associations were observed in Central California. Additionally, the authors did not observe any associations between nighttime heat waves and hospitalizations.2

“We found that both daily high heat events and extreme temperatures that lasted several days increased the risk of asthma hospital visits,” said corresponding author Morgan Ye, MPH, research data analyst, Division of Pulmonary and Critical Care Medicine, University of California, San Francisco School of Medicine, in a news release. “Understanding the impacts of climate-sensitive events such as extreme heat on a vulnerable population is the key to reducing the burden of disease due to climate change.”1

Additionally, the authors note that there were conflicting findings regarding hospitalizations and emergency room visits. They also note that the study is unique because no prior research has investigated the effect of daily high temperatures, while also considered the effects of persistent extreme temperatures in a pediatric population with asthma.1

“We continue to see global temperatures rise due to human-generated climate change, and we can expect a rise in health-related issues as we observe longer, more frequent, and severe heat waves. Our research suggests that higher temperatures and increased duration of these high heat days are associated with increased risk of hospital visits due to asthma. Children and families with lower adaptation capacity will experience most of the burden,” said Ye in the news release. “Therefore, it is important to obtain a better understanding of these heat-associated health risks and susceptible populations for future surveillance and targeted interventions.”1

The authors note that the findings were more evident in populations more susceptible to the changing climate, such as children or people who are considered more vulnerable medically. According to the authors, the findings from this study can help lead to more equitable health outcomes while reducing racial or ethnic disparities that are often present in climate-sensitive events.1

“These results can be used to inform targeted actions and resources for vulnerable children and alleviate health-related stress during heat waves,” the authors said in the news release.1

References
  1. American Thoracic Society. Extreme Heat Associated With Children's Asthma Hospital Visits. News release. May 13, 2024. Accessed May 23, 2024. https://www.newswise.com/articles/view/810781/?sc=sphr&xy=10026574
  2. Ye, M, Ndovu, A, Nguyen, AV, Long, D, Benmarhnia, T, and Thakur, N. Extreme Heat and Asthma Hospitalizations in Children in California (2017-2020) (abstract). Am J Respir Crit Care Med 2024;209:A2728 doi:10.1164/ajrccm-conference.2024.209.1_MeetingAbstracts.A2728
Related Videos
Happy elderly patient with medical health checkup with cardiologist or geriatric doctor. Senior old aging woman with coronary artery heart disease or cardiac illness check-up in clinic - Image credit: Chinnapong | stock.adobe.com
Image credit: Photo18@desing | stock.dobe.com
Related Content
Advertisement
Red blood cells | Image Credit: © fotogurmespb - stock.adobe.com
May 15th 2025

Interferon Lowers Myelofibrosis Risk in Young Patients With Polycythemia Vera, Essential Thrombocytopenia

Alexandra Gerlach, Associate Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Microscopic cellular structure of chronic lymphocytic leukemia | Image Credit: ©AI Photo Stock - stock.adobe.com
May 15th 2025

Real-World Study Shows Comparable Survival Outcomes With First-Line Ibrutinib in High-Risk and Non-High-Risk CLL/SLL

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Psilocybin -- Image credit: TaylerDerden | stock.adobe.com
May 15th 2025

The Promise of Psilocybin-Assisted Therapy for Opioid Use Disorder

Craig Kimble, PharmD, MBA, MS, BCACP, TTS Alberto Coustasse, DrPH, MD, MBA, MPH
X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
May 15th 2025

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Gillian McGovern, Associate Editor
Related Content
Advertisement
Red blood cells | Image Credit: © fotogurmespb - stock.adobe.com
May 15th 2025

Interferon Lowers Myelofibrosis Risk in Young Patients With Polycythemia Vera, Essential Thrombocytopenia

Alexandra Gerlach, Associate Editor
pharmacy focus oncology edition
May 12th 2025

Insights from a Pharmacy Times Peer Exchange: Emerging ADCs and Real-World Management

Alexandra Gerlach, Associate Editor
Microscopic cellular structure of chronic lymphocytic leukemia | Image Credit: ©AI Photo Stock - stock.adobe.com
May 15th 2025

Real-World Study Shows Comparable Survival Outcomes With First-Line Ibrutinib in High-Risk and Non-High-Risk CLL/SLL

Alexandra Gerlach, Associate Editor
Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
May 6th 2025

Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management

Aislinn Antrim, Managing Editor Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Psilocybin -- Image credit: TaylerDerden | stock.adobe.com
May 15th 2025

The Promise of Psilocybin-Assisted Therapy for Opioid Use Disorder

Craig Kimble, PharmD, MBA, MS, BCACP, TTS Alberto Coustasse, DrPH, MD, MBA, MPH
X-ray image depicting a migraine -- Image credit: peterschreiber.media | stock.adobe.com
May 15th 2025

FDA Approves Brekiya, First and Only DHE Autoinjector, for Acute Treatment of Migraine, Cluster Headaches

Gillian McGovern, Associate Editor
Consent Preferences
About Us
Clinical Forums
Advertise
Contact Us
Editorial Staff
Privacy Policy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.